Double-Blind Placebo-Controlled Parallel Design Phase 2 Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Postmenopausal Women with Stress Urinary Incontience

Double-Blind Placebo-Controlled Parallel Design Phase 2 Study to Assess Clinical Activity and Safety of Enobosarm (GTx-024) in Postmenopausal Women with Stress Urinary Incontience
99 years or below
All
1 Location

Brief description of study

TBD

Eligibility of study

You may be eligible for this study if you meet the following criteria:

  • Conditions: TBD, tbd, tbd
  • Age: 99 years or below
  • Gender: All
Updated on 27 Aug 2018. Study ID: 828237

Message For Non Enrolling By Invitation Trial

Select a study center that’s convenient for you, and get in touch with the study team.